US 7,456,268 B2
Materials and methods for inhibiting Wip1
Dmitry Bulavin, Singapore (Singapore); Ettore Appella, Chevy Chase, Md. (US); Albert J. Fornace, Jr., Bethesda, Md. (US); and Anne Kallioniemi, Tampere (Finland)
Assigned to The United States of America as represented by the Department of Health and Human Services, Washington, D.C. (US)
Filed on Oct. 08, 2007, as Appl. No. 11/868,794.
Application 11/868794 is a continuation of application No. 10/507701, abandoned, previously published as PCT/US03/08997, filed on Mar. 21, 2003.
Claims priority of provisional application 60/366883, filed on Mar. 22, 2002.
Prior Publication US 2008/0081065 A1, Apr. 03, 2008
Int. Cl. C07H 1/00 (2006.01); C07H 5/00 (2006.01); C07H 19/00 (2006.01); C07H 21/00 (2006.01); C07H 21/02 (2006.01); C08B 37/00 (2006.01)
U.S. Cl. 536—22.1  [536/1.11; 536/18.7; 536/23.1; 536/24.3; 536/24.31; 536/24.5] 2 Claims
 
1. An isolated or purified oligonucleotide consisting essentially of the nucleotide sequence of SEQ ID NO: 1.